| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 118 | 2021 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 106 | 2019 |
| Survival after severe acute chromic acid poisoning complicated with renal and liver failure M Barešic, I Gornik, R Radonic, O Zlopaša, N Gubarev, V Gašparovic Internal medicine 48 (9), 711-715, 2009 | 25 | 2009 |
| Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature G Šukara, M Barešić, M Sentić, L Brčić, B Anić Acta Reumatológica Portuguesa 40 (2), 169-175, 2015 | 23 | 2015 |
| Rare zoonosis (hemotrophic mycoplasma infection) in a newly diagnosed systemic lupus erythematosus patient followed by a Nocardia asteroides pneumonia D Bosnic, M Baresic, B Anic, M Sentic, M Cerovec, M Mayer, N Cikes Brazilian Journal of Infectious Diseases 14, 92-95, 2010 | 21 | 2010 |
| Fever of unknown origin: large vessel vasculitis diagnosed by PET/CT D Bosnić, M Barešić, I Padjen, A Balenović, K Žarković, B Anić Rheumatology international 33, 2417-2421, 2013 | 18 | 2013 |
| Solitary pulmonary amyloidoma mimicking lung cancer on 18F-FDG PET-CT scan in systemic lupus erythematosus patient M Barešić, KB Sreter, L Brčić, A Hećimović, Z Janevski, B Anić Lupus 24 (14), 1546-1551, 2015 | 15 | 2015 |
| Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study Z Izadi, MA Gianfrancesco, G Schmajuk, L Jacobsohn, P Katz, S Rush, ... The Lancet Rheumatology 4 (9), e603-e613, 2022 | 14 | 2022 |
| Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region A Lescoat, D Huscher, N Schoof, P Airò, J de Vries-Bouwstra, ... Rheumatology 62 (6), 2178-2188, 2023 | 12 | 2023 |
| Subcutaneous sarcoidosis of the face D Bosnic, M Barešic, D Bagatin, I Ilic Internal medicine 49 (6), 589-592, 2010 | 12 | 2010 |
| Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model A Garaiman, K Steigmiller, C Gebhard, C Mihai, R Dobrota, C Bruni, ... Rheumatology 62 (SI), SI91-SI100, 2023 | 9 | 2023 |
| Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry R Conway, E Nikiphorou, CA Demetriou, C Low, K Leamy, JG Ryan, ... Rheumatology 61 (SI2), SI151-SI156, 2022 | 9 | 2022 |
| Hereditary angioedema due to C1-inhibitor deficiency in pediatric patients in Croatia–first National Study, diagnostic and prophylactic challenges L Karadža-Lapić, M Barešić, R Vrsalović, I Ivković-Jureković, S Sršen, ... Acta Clinica Croatica 58 (1), 139, 2019 | 9 | 2019 |
| Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis. V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis Rheumatology 31, 44Z, 2019 | 8 | 2019 |
| Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma: data from the international EUSTAR database A Lescoat, S Huang, PE Carreira, E Siegert, J de Vries-Bouwstra, ... JAMA dermatology 159 (8), 837-847, 2023 | 7 | 2023 |
| Delphi-based consensus on interstitial lung disease screening in patients with connective tissue diseases (croatian national-based study) M Radić, S Novak, M Barešić, A Hećimović, D Perković, ... Biomedicines 10 (12), 3291, 2022 | 7 | 2022 |
| Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab D Bosnić, B Žarković, M Barešić, M Zarkovic, B Anić Reumatologia/Rheumatology 54 (6), 321-325, 2016 | 7 | 2016 |
| The lobster sign in SAPHO syndrome: unusually extensive osteitis of the anterior chest wall partially responsive to infliximab B Anić, I Padjen, M Barešić, S Težak Rheumatology international 34, 281-282, 2014 | 7 | 2014 |
| Improvement of neurological and ocular symptoms of Behçet’s disease after the introduction of infliximab M Barešić, M Reihl, M Habek, N Vukojević, B Anić Rheumatology international 38 (7), 1301-1306, 2018 | 6 | 2018 |
| Different therapeutic paths (colchicine vs. anakinra) in two patients with Schnitzler’s Syndrome M Barešić, J Mitrović, JM Vergles, A Branimir Archives of Rheumatology 31 (4), 377, 2016 | 6 | 2016 |
